Erratum: Horse versus rabbit antithymocyte globulin in acquired aplastic anemia (New England Journal of Medicine (2011) 365 (430-438) DOI: 10.1056/NEJMoa1103975);Horse versus rabbit antithymocyte globulin in acquired aplastic anemia

New England Journal of Medicine

Volumn 365, Issue 5, 2011, Pages 430-438

  Scheinberg, Phillip ^a   Nunez, Olga ^a   Weinstein, Barbara ^a   Scheinberg, Priscila ^a   Biancotto, Angélique ^b   Wu, Colin O ^a   Young, Neal S ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLOOD CELL COUNT; BRAIN HEMORRHAGE; CHILD; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; FEMALE; HORSE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; OVERALL SURVIVAL; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RABBIT; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEPSIS; SEPTICEMIA; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE;

EID: 79961116424     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMx180020     Document Type: Erratum

References (32)

1. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108:2509-19.
2. Mathé G, Amiel JL, Schwarzenberg L, et al. Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J 1970;2:131-6.
3. Speck B, Gratwohl A, Nissen C, et al. Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. Br Med J (Clin Res Ed) 1981;282:860-3. (Pubitemid 11136604)
4. Locasciulli A, Oneto R, Bacigalupo A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007;92:11-8. (Pubitemid 46232653)
5. Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991;324:1297-304.
6. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995;85:3058-65.
7. Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood 2000;95:1931-4. (Pubitemid 30151628)
8. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymo- cyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000;96:2049-54.
9. Führer M, Burdach S, Ebell W, et al. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. Klin Padiatr 1998;210:173-9. (Pubitemid 28361236)
10. Scheinberg P, Nunez O, Wu C, Young NS. Treatment of severe aplastic anaemia with combined immunosuppression: antithymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 2006;133:606-11. (Pubitemid 43742774)
11. Scheinberg P, Wu CO, Nunez O, Boss C, Sloand EM, Young NS. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 2009;94:348-54.
12. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003;289:1130-5. (Pubitemid 37430327)
13. Brennan DC, Flavin K, Lowell JA, et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 1999;67:1011-8. [Erratum, Transplantation 1999;67:1386.]
14. Gaber AO, First MR, Tesi RJ, et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998;66:29-37. (Pubitemid 28341164)
15. Di Bona E, Rodeghiero F, Bruno B, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Br J Haematol 1999;107:330-4. (Pubitemid 29530219)
16. Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol 2006;133:622-7. (Pubitemid 43742776)
17. Scheinberg P, Fischer SH, Li L, et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007;109:3219-24. (Pubitemid 46578057)
18. Feng X, Kajigaya S, Solomou EE, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25high FOXP3+ regulatory T cells in vitro. Blood 2008;111:3675-83.
19. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 2006;17: 2844-53. (Pubitemid 44484674)
20. Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol 2006;27:541-4. (Pubitemid 44780852)
21. Garg R, Faderl S, Garcia-Manero G, et al. Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome. Leukemia 2009;23:1297-302.
22. Atta EH, Dias DD, Marra VL, de Azevedo AM. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol 2010;89:851-9.
23. Vallejo C, Montesinos P, Rosell A, et al. Comparison between lymphoglobulineand thymoglobuline-based immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood 2009;114(22):3194. abstract.
24. Raefsky EL, Gascon P, Gratwohl A, Speck B, Young NS. Biological and immunological characterization of ATG and ALG. Blood 1986;68:712-9. (Pubitemid 16008176)
25. LaCorcia G, Swistak M, Lawendowski C, et al. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion. Transplantation 2009;87:966-74.
26. Ayuk F, Maywald N, Hannemann S, Larsen U, Zander A, Kroger N. Comparison of the cytotoxicity of 4 preparations of anti-T-cell globulins in various hematological malignancies. Anticancer Res 2009;29:1355-60.
27. Scheinberg P, Wu CO, Scheinberg P, Nunez O, Sloand EM, Young NS. Alemtuzumab (Campath) monotherapy for severe aplastic anemia. Blood 2010;116(21):1167. abstract.
28. Hanash AM, Levy RB. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 2005;105:1828-36. (Pubitemid 40223710)
29. Kawano Y, Nissen C, Gratwohl A, Würsch A, Speck B. Cytotoxic and stimulatory effects of antilymphocyte globulin (ALG) on hematopoiesis. Blut 1990;60:297-300. (Pubitemid 20185541)
30. Barbano GC, Schenone A, Roncella S, et al. Anti-lymphocyte globulin stimulates normal human T cells to proliferate and to release lymphokines in vitro: a study at the clonal level. Blood 1988;72:956-63.
31. Naparstek E, Delukina M, Or R, et al. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies. Exp Hematol 1999;27:1210-8. (Pubitemid 29284329)
32. Passweg JR, Tichelli A. Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Haematologica 2009;94:310-2.